Human Abuse Potential: Subjective Ratings

Human Abuse Potential studies depend on more than protocol design—they hinge on the quality and consistency of participant-reported data. Because these studies rely on subjective ratings from individuals experienced with the drug class being evaluated, the way those ratings are collected and interpreted is critical to accurately assessing abuse potential. In this third installment of the Human Abuse Potential Study Series, Rose Gerringer, Ratings Manager at Dr. Vince Clinical Research, explains how subjective ratings are captured using Visual Analog Scales and why trained, consistent administration matters. She also explores key factors that can influence participant responses and outlines best practices for ensuring reliable, high-quality data.

Watch to gain a deeper understanding of how careful ratings management supports regulatory-grade HAP outcomes.